Abstract
Levosimendan (Levo) is an inodilator improving cardiac output (CO) and reducing afterload in heart failure. Previously, we reported that Levo improved CO but not blood pressure (BP) in a rodent model of verapamil poisoning. We theorised that Levo-induced vasodilation should not influence BP to a similar degree in metoprolol poisoning.
Original language | English |
---|---|
Pages (from-to) | 955 - 963 |
Number of pages | 9 |
Journal | Human and Experimental Toxicology |
Volume | 31 |
Issue number | 9 |
DOIs | |
Publication status | Published - 2012 |